Virologic outcomes in early antiretroviral treatment: HPTN 052
© 2017 Informa UK Limited, trading as Taylor & Francis Group. Introduction: The HIV Prevention Trials Network (HPTN) 052 trial demonstrated that early antiretroviral therapy (ART) prevented 93% of HIV transmission events in serodiscordant couples. Some linked infections were observed shortly a...
محفوظ في:
المؤلفون الرئيسيون: | Susan H. Eshleman, Ethan A. Wilson, Xinyi C. Zhang, San San Ou, Estelle Piwowar-Manning, Joseph J. Eron, Marybeth McCauley, Theresa Gamble, Joel E. Gallant, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James G. Hakim, Ben Kalonga, Jose H. Pilotto, Beatriz Grinsztejn, Sheela V. Godbole, Nuntisa Chotirosniramit, Breno Riegel Santos, Emily Shava, Lisa A. Mills, Ravindre Panchia, Noluthando Mwelase, Kenneth H. Mayer, Ying Q. Chen, Myron S. Cohen, Jessica M. Fogel |
---|---|
التنسيق: | دورية |
منشور في: |
2018
|
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017113091&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/47172 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Chiang Mai University |
مواد مشابهة
-
Virologic outcomes in early antiretroviral treatment: HPTN 052
بواسطة: Susan H. Eshleman, وآخرون
منشور في: (2018) -
Virologic outcomes in early antiretroviral treatment: HPTN 052
بواسطة: Eshleman S., وآخرون
منشور في: (2017) -
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
بواسطة: Philip J. Palumbo, وآخرون
منشور في: (2018) -
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
بواسطة: Philip J. Palumbo, وآخرون
منشور في: (2018) -
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
بواسطة: Philip J. Palumbo, وآخرون
منشور في: (2018)